O'Keefe Stevens Advisory, Inc. Bristol Myers Squibb CO Transaction History
O'Keefe Stevens Advisory, Inc.
- $305 Million
- Q3 2024
A detailed history of O'Keefe Stevens Advisory, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, O'Keefe Stevens Advisory, Inc. holds 4,570 shares of BMY stock, worth $254,868. This represents 0.08% of its overall portfolio holdings.
Number of Shares
4,570Holding current value
$254,868% of portfolio
0.08%Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,444Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.4 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.85 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.1 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.16 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.29 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...